Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists

US Patent 6548516 · Granted Apr 15, 2003

Estimated economic value: $79,982,000

Assignee

Inventors

View full patent text on Google Patents →